Stoneridge Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,144
| Closed | -$331K | – | 109 |
|
|
2022
Q3 | $331K | Sell |
1,144
-851
| -43% | -$246K | 0.19% | 79 |
|
|
2022
Q2 | $562K | Buy |
+1,995
| New | +$562K | 0.31% | 75 |
|
|
2022
Q1 | – | Sell |
-1,138
| Closed | -$250K | – | 132 |
|
|
2021
Q4 | $250K | Sell |
1,138
-2,600
| -70% | -$571K | 0.12% | 103 |
|
|
2021
Q3 | $678K | Buy |
3,738
+1,550
| +71% | +$281K | 0.34% | 73 |
|
|
2021
Q2 | $441K | Hold |
2,188
| – | – | 0.21% | 85 |
|
|
2021
Q1 | $470K | Buy |
2,188
+450
| +26% | +$96.7K | 0.25% | 81 |
|
|
2020
Q4 | $411K | Buy |
+1,738
| New | +$411K | 0.24% | 89 |
|